The global triamcinolone acetonide injection market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). The synthetic corticosteroid, triamcinolone acetonide injection works by decreasing the release of chemicals that trigger allergies and other inflammatory responses. It can be used to treat asthma, chronic obstructive pulmonary disease (COPD), arthritis, and psoriasis in adults and children over the age of six. According to World Health Organization (WHO), asthma is the most common chronic disease among children. Asthma affected an estimated 262 million people in 2019 and caused 461000 deaths. Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of death worldwide, causing 3.23 million deaths in 2019. Over 80% of these deaths occurred in low- and middle-income countries.
(Get 15% Discount on Buying this Report)
A full report is available at : https://orionmarketreports.com/global-triamcinolone-acetonide-injection-market/92795/
The market players are helping significantly in the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay in the competition of the market. For instance, in October 2021, Bausch + Lomb along with Bausch Health Companies Inc. and Clearside Biomedical, Inc., announced that the US Food and Drug Administration (FDA) has approved XIPERE (triamcinolone acetonide injectable suspension) for suprachoroidal use for the treatment of macular edema associated with uveitis, a form of eye inflammation.
Market Coverage
The market number available for – 2022-2028
Base year- 2021
Forecast period- 2022-2028
Segment Covered-
By Type
By Application
By Distribution Channel
Regions Covered-
- North America
- Europe
- Asia-Pacific
Rest of the World
Competitive Landscape– G&W laboratories Inc., Lannett Co. Inc., Perrigo Co. PLC, Taro Pharmaceutical Industries Ltd., Mylan NV, Lupin Inc. and Teva Pharmaceutical Industries Ltd. among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
- Deviation from the pre-COVID-19 forecast
- Most affected region and segment
- Who is the leader in the market?
- How are playersaddressing challenges to sustain growth?
- Where is the investment opportunity?
Global Triamcinolone Acetonide Injection Market Report by Segment
By Type
- 1 ml vial
- 5 ml vial
- 10 ml vial
By Application
- Arthritic Disorders
- Dermatoses
- Multiple Sclerosis
- Allergic Conditions
- Others
By Distribution Channel
- Hospitals
- Drug Stores
- Others
About Us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company Name : Orion Market Reports
Contact Person : Mr. Anurag Tiwari
Email : Info@orionmarketreports.com
Contact No : +91 780-304-0404
This release has been published on Global market Post
Global market Post is not responsible for any content included in this release.
